BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 16754822)

  • 1. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
    Kaplan P; Andersson HC; Kacena KA; Yee JD
    Arch Pediatr Adolesc Med; 2006 Jun; 160(6):603-8. PubMed ID: 16754822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.
    Zevin S; Abrahamov A; Hadas-Halpern I; Kannai R; Levy-Lahad E; Horowitz M; Zimran A
    Q J Med; 1993 Sep; 86(9):565-73. PubMed ID: 8255971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
    Piran S; Roberts A; Patterson MA; Amato D
    Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
    Drelichman G; Ponce E; Basack N; Freigeiro D; Aversa L; Graciela E; Kohan R
    J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
    Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
    Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gaucher's disease in childhood: presentation and treatment].
    Maaswinkel-Mooij PD; Kerstjens-Frederikse WS; de Koning J; Kok AJ; Poorthuis BJ
    Tijdschr Kindergeneeskd; 1992 Dec; 60(6):231-5. PubMed ID: 1488736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
    Sobreira E; Pires RF; Cizmarik M; Grabowski GA
    Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J; Szücs FZ; Benkö K; Maródi L
    Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenotype and mutational spectrum in Tunisian pediatric gaucher disease].
    Ben Turkia H; Riahi I; Azzouz H; Ladab S; Cherif W; Ben Chehida A; Abdelmoula MS; Caillaud C; Chemli J; Abdelhak S; Tebib N; Ben Dridi MF
    Tunis Med; 2010 Mar; 88(3):158-62. PubMed ID: 20415187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presenting signs and symptoms in Gaucher disease].
    Erdös M; Tóth J; Maródi L
    Orv Hetil; 2002 Oct; 143(41):2327-35. PubMed ID: 12434734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miscellaneous non-inflammatory musculoskeletal conditions. Gaucher disease and bone.
    Mikosch P
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):665-81. PubMed ID: 22142746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gaucher disease type I diagnosed at 63 years old presenting with thrombocytopenia].
    Kawahara S; Kato A; Oshimi K; Ida H
    Rinsho Ketsueki; 2008 May; 49(5):335-9. PubMed ID: 18572811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention.
    Mistry PK; Sadan S; Yang R; Yee J; Yang M
    Am J Hematol; 2007 Aug; 82(8):697-701. PubMed ID: 17492645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline characteristics of 32 patients with Gaucher disease who were treated with imiglucerase: South African data from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
    Sevittz H; Laher F; Varughese ST; Nel M; McMaster A; Jacobson BF
    S Afr Med J; 2022 Feb; 112(1):13518. PubMed ID: 35140000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher's disease;thirty-two years experience at Siriraj Hospital.
    Tanphaichitr VS; Suvatte V; Mahasandana C; Sachapong P; Veerakul G; Kankirawatana S; Wasant P
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():143-7. PubMed ID: 11400753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and enzyme studies in Gaucher disease.
    Kaur M; Kabra M; Kher A; Naik G; Bharucha BA; Verma IC
    Indian Pediatr; 1996 Sep; 33(9):735-8. PubMed ID: 9057400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
    Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
    Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM; Elstein D; Hrebícek M; Zimran A
    Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gaucher disease: importance of early diagnosis and therapy].
    Simon G; Erdos M; Maródi L; Tóth J
    Orv Hetil; 2008 Apr; 149(16):743-50. PubMed ID: 18426721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthopaedic manifestations of Gaucher disease.
    Lutsky KF; Tejwani NC
    Bull NYU Hosp Jt Dis; 2007; 65(1):37-42. PubMed ID: 17539760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.